Ultragenyx Pharmaceutical Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 2,227 | 0.0% | 96,836 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,790 | 0.0% | 92,766 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 3,415 | 0.0% | 93,909 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 3,383 | 0.0% | 93,439 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 3,931 | 0.0% | 93,439 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 4,976 | 0.0% | 89,569 | 9/30/2024 |
| 2024 Q2 | 8/8/2024 | 3,681 | 0.0% | 89,569 | 6/30/2024 |
| 2024 Q1 | 5/8/2024 | 3,516 | 0.0% | 87,673 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 4,092 | 0.0% | 85,569 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 3,012 | 0.0% | 84,482 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 3,888 | 0.0% | 84,282 | 6/30/2023 |
| 2023 Q1 | 6/14/2023 | 3,516 | 0.0% | 87,673 | 3/31/2023 |
| 2022 Q4 | 6/14/2023 | 4,062 | 0.0% | 87,673 | 12/31/2022 |
| 2022 Q3 | 11/8/2022 | 3,756 | 0.0% | 90,713 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 5,412 | 0.0% | 90,713 | 6/30/2022 |
| 2022 Q1 | 5/6/2022 | 6,213 | 0.0% | 85,551 | 3/31/2022 |
| 2021 Q4 | 2/8/2022 | 7,287 | 0.0% | 86,652 | 12/31/2021 |
| 2021 Q3 | 11/8/2021 | 7,776 | 0.0% | 86,213 | 9/30/2021 |
| 2021 Q2 | 8/10/2021 | 8,415 | 0.0% | 88,253 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 2,735 | 0.0% | 24,025 | 3/31/2021 |
| 2020 Q4 | 2/8/2021 | 3,578 | 0.0% | 25,845 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 2,376 | 0.0% | 28,905 | 9/30/2020 |
| 2020 Q2 | 8/7/2020 | 2,216 | 0.0% | 28,325 | 6/30/2020 |
| 2020 Q1 | 5/5/2020 | 1,283 | 0.0% | 28,885 | 3/31/2020 |
| 2019 Q4 | 2/3/2020 | 1,234 | 0.0% | 28,885 | 12/31/2019 |